Drug Industry Daily

Feb. 3, 2004 | Vol. 3 No. 22

OPM EXPANDS PROBE INTO MARKETING OF PSYCHIATRIC DRUGS

Wyeth Pharmaceuticals and Forest Laboratories have revealed that the federal Office of Personnel Management (OPM) has issued subpoenas for documents relating to antidepressants marketed by the two drugmakers.

This article is viewable by subscribers only. To view this article, please select an option below.

Subscribe
Print This Page
Email This Article
RSS
Free Trial
Archives
Sample PDF

Study: Teva's Copaxone the Better Treatment Option for MS FDA Work Force Needs Major Changes, Von Eschenbach Says Not All Adverse Events in Clinical Trials Should Be Reported to IRBs GSK Warns of Label Tampering on HIV Medications

Home
Advertising/Sponsorships
About Us
Contact Us
Site Map
Privacy Policy

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA.
Phone (703) 538-7600 - Fax (703) 538-7676 - Toll free (888) 838-5578.